University Chemistry ›› 2024, Vol. 39 ›› Issue (12): 202-207.doi: 10.12461/PKU.DXHX202403099

Special Issue:

• Survey of Chemistry • Previous Articles     Next Articles

Monoclonal Antibody Drugs: Breakthroughs and Hope in the Field of Biomedical Sciences

Yuxin Zhang1, Haocheng Huang1, Wenzhuo Zhang1, Lushun Zhou1, Yawei Lin1, Zhenyu He2   

  1. 1 School of Chemistry, Chemical Engineering & Life Sciences, Wuhan University of Technology, Wuhan 430070, China;
    2 Wuhan Center for Disease & Prevention, Wuhan 430060, China
  • Received:2024-03-27 Accepted:2024-07-04 Published:2024-12-17
  • Contact: Yawei Lin, Zhenyu He E-mail:linyawei2012@whut.edu.cn;hosan9174@163.com

Abstract: Compared to traditional drugs, monoclonal antibody (mAb) drugs distinguish themselves through their excellent specificity. They are capable of precisely recognizing and binding to target antigens, accurately localizing to diseased sites, and intervening in specific disease processes, thereby minimizing damage to other parts of the body and reducing side effects. MAb drugs play an important role in disease prevention and treatment, characterized by their unique structural functions, stringent preparation processes, and widely acknowledged safety. This article introduces the structure and functions of mAb drugs, along with their preparation processes, and emphasizes their significant contributions to the treatment of tumor, autoimmune diseases, and infectious diseases.

Key words: Monoclonal antibody, Preparation of monoclonal antibody drugs, Quality control of monoclonal antibody drugs